Batavia Bioservices | Biotechnology Life Science Product/Process Development, Manifacturing Biopharmaceutical materials | Bioscience Park Leiden

Batavia Bioservices aims to significantly contribute to ease human suffering from disease by improving the success rate in the translation of candidate medicines from discovery to the clinic.

In the rapidly growing market of biopharmaceuticals we offer our novel technologies and know how in order to help our customers to complete their preclinical phases in product development at higher speed, reduced cost, and with higher success rate.

read more >>
Batavia Bioservices | Biotechnology Life Science Product/Process Development, Manifacturing Biopharmaceutical materials | Bioscience Park Leiden

Current vacancies

Currently we are looking for (a):
-  Sales Manager, Leiden, The Netherlands
-  Account Manager, Leiden, The Netherlands
-  Associate Scientist Cell Sciences, Woburn
-  (associate) Scientist Molecular Biology, Vector Technology, Woburn
-  Team Leader USP, Leiden, The Netherlands
-  Project Manager, Leiden, The Netherlands
-  Team Leader Analytical Assays, Leiden, The Netherlands

The Boys & Girls Club of Woburn receives tricycles with great pleasure

The Boys & Girls Club receives tricycles with great pleasureMenzo Havenga, CEO Batavia Bioservices Inc., was very pleased to hand over four tricycles at the Boys & Girls Club of Woburn in June 2014. The Boys & Girls Club of Woburn is a non-profit organization serving youth in Woburn and surrounding communities.

read more >>

Batavia Bioservices announced the appointment of Dr. Fija Lagerwerf as Manager Operations

Batavia Bioservices announced the appointment of Dr. Fija Lagerwerf as Manager Operations per July 1st, 2014. Dr. Lagerwerf brings to Batavia Bioservices more than 15 years of managerial experience in biopharmaceutical process development, analytical development, Quality Control & Immunology.

read more >>

Interview Menzo Havenga with Leiden.nu

Interview van Menzo Havenga Leiden.nuOn the website Leiden.nu there is an interview published with our CEO, Menzo Havenga. The interview is in Dutch.
Click here for the article >>

Interview van Menzo Havenga met BNR radio

Interview van Menzo Havenga met BNR radioKlik hier om het interview van Menzo Havenga met BNR radio te beluisteren >>

Batavia Bioservices is awarded for the FD Gazellen Diversity Award 2013

Batavia Bioservices is awarded the title FD Gazellen company 2013According to the jury: "By using new technology and know-how in a fast growing market Batavia Bioservices is able to complete preclinical stages of product development much faster and at reduced cost. Batavia Bioservices created a workplace that reflects the diversity of our clients and society. Women are represented in the Management Team and at Scientific level."

Dr. Menzo Havenga, made it to the Final of the "Entrepreneur of the Year 2013"

Dr. Menzo Havenga, made it to the Final of the Entrepreneur of the Year 2013 During an exhilarating final in Rotterdam on October the 5th, the winners of the EY entrepreneur of the year contest 2013 were chosen.
read more >>

Batavia Bioservices and UvA Holding announce STEP(TM) technology exclusive license

logo STEPBatavia Bioservices BV and UvA Holding BV announced today that they have successfully concluded an agreement granting Batavia Bioservices the exclusive rights to STEP(TM) technology developed by scientists at CellaGenics BV, an UvA Holding BV company.
read more >>

Batavia Bioservices is awarded the title FD Gazellen company 2013 Dr. Menzo Havenga, made it to the Final of the Entrepreneur of the Year 2013
Batavia Bioservices

Batavia Bioservices offers a portfolio of services focused on the rapid and cost effective provision of high quality biopharmaceutical materials for research and pre-clinical studies. Services include:

Batavia Bioservices is strongly committed to the development of new technologies and innovations within the field of biopharmaceutical research and development. We focus on technology which ultimately leads to the development of better medicines at reduced cost and time.